John M Vierling

7PUBLICATIONS
50CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Clinical pharmacology and therapeuticsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon, Alejandra Villamil, Ira M Jacobson

|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.

Cynthia Levy, Palak J Trivedi, Kris V Kowdley

|Oct 31, 2023
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.

Marlyn J Mayo, John M Vierling, Christopher L Bowlus

|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein

|Nov 30, 2021
Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).

Wayne Eskridge, John M Vierling, Wayne Gosbee

Pageof 2

Frequent Collaborators

4 joint publications

Gideon M Hirschfield

4 joint publications

Cynthia Levy

4 joint publications

Christopher L Bowlus

3 joint publications

Palak Trivedi